We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$228B
AUM Growth
+$19.5B
Cap. Flow
+$9.66B
Cap. Flow %
4.24%
Top 10 Hldgs %
19.68%
Holding
7,447
New
331
Increased
2,461
Reduced
3,156
Closed
486

Sector Composition

Rank Sector Weight
1 Financials 21.58%
2 Energy 8.65%
3 Industrials 8.54%
4 Technology 7.61%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMBK icon
6726
SmartFinancial
SMBK
$898M
$0 ﹤0.01%
21
-551
-96% -$12.7K
SMSI icon
6727
Smith Micro Software
SMSI
$17M
0
SMTC icon
6728
CALL
Semtech
SMTC
$13B
-22,700
Closed -$852K
SNDA icon
6729
Sonida Senior Living
SNDA
$1.88B
-148
Closed -$31.7K
SNDX icon
6730
Syndax Pharmaceuticals
SNDX
$1.77B
$0 ﹤0.01%
29
-804
-97% -$7.96K
SNFCA icon
6731
Security National Financial
SNFCA
$242M
$0 ﹤0.01%
11
SNOA icon
6732
Sonoma Pharmaceuticals
SNOA
$6.56M
0
SONN
6733
DELISTED
Sonnet BioTherapeutics
SONN
0
SOXS icon
6734
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.41B
0
-$211K
SPYM
6735
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
-17,820
Closed -$526K
SPUU icon
6736
Direxion Daily S&P 500 Bull 2X ETF
SPUU
$282M
-655
Closed -$29K
SSKN
6737
DELISTED
Strata Skin Sciences
SSKN
$0 ﹤0.01%
+1
New +$14
SSRM icon
6738
CALL
SSR Mining
SSRM
$6.63B
-400,000
Closed -$4.24M
SSRM icon
6739
PUT
SSR Mining
SSRM
$6.63B
-110,000
Closed -$1.17M
STEL
6740
DELISTED
Stellar Bancorp
STEL
$0 ﹤0.01%
+6
New +$173
STKS icon
6741
The ONE Group
STKS
$56.5M
$0 ﹤0.01%
15
STLD icon
6742
CALL
Steel Dynamics
STLD
$37.7B
-293,000
Closed -$10.1M
STLD icon
6743
PUT
Steel Dynamics
STLD
$37.7B
-67,900
Closed -$2.34M
STN icon
6744
CALL
Stantec
STN
$8.47B
-88,000
Closed -$2.44M
STN icon
6745
PUT
Stantec
STN
$8.47B
-74,000
Closed -$2.05M
STRS
6746
DELISTED
STRATUS PPTYS INC
STRS
$0 ﹤0.01%
9
-531
-98% -$15.9K
SWK icon
6747
CALL
Stanley Black & Decker
SWK
$15.5B
-39,000
Closed -$5.89M
SYF icon
6748
PUT
Synchrony
SYF
$25.8B
-10,000
Closed -$311K
SYPR icon
6749
Sypris Solutions
SYPR
$46.8M
$0 ﹤0.01%
14
SYRE icon
6750
Spyre Therapeutics
SYRE
$9.18B
0

Similar funds

Royal Bank of Canada's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.

  • Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
  • Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
  • Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
  • Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
  • Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.